Zelda Therapeutics (ASX: ZLD)
Zelda Therapeutics (ASX: ZLD) is a biotech company active in the study and use of medicinal cannabis to treat a variety of ailments and medical conditions. www.zeldatherapeutics.com
Health House Holdings to distribute Zelda Therapeutics’ medicinal cannabis throughout Australasia and UK
Zelda Therapeutics’ (ASX: ZLD) medicinal cannabis products will be distributed across Australasia and the United Kingdom under...
Zelda Therapeutics granted approval to trial medicinal cannabis in tackling the opioid epidemic
Bio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has taken a decisive step towards mitigating the effects of the...
SUDA Pharmaceuticals and Zelda Therapeutics to develop novel medicinal cannabis oral spray
Drug delivery specialist company SUDA Pharmaceuticals (ASX: SUD) has unveiled a deal with Zelda Therapeutics (ASX: ZLD) in...
Zelda Therapeutics commences its ‘pioneering’ insomnia trial using cannabis
Dual-listed biopharma company Zelda Therapeutics (ASX: ZLD) has kicked off its “pioneering” insomnia trial by dosing its...
IRB approval paves way for Zelda to begin cannabis trials in paediatric autism
Zelda Therapeutics (ASX: ZLD) has gained Institutional Review Board approval to trial its cannabinoid-based formulations on children...
Zelda Therapeutics broadens pancreatic cancer research as precursor to human trials
Zelda Therapeutics (ASX: ZLD) and West Australian-based Curtin University have broadened their pancreatic cancer research program to...
Zelda Therapeutics announces US stock market listing
Zelda Therapeutics (ASX: ZLD), an Australian biotech company focusing on medical cannabis, has announced that its shares...
Zelda Therapeutics teams up with US children’s hospital for medicinal cannabis autism study
Zelda Therapeutics (ASX: ZLD) has teamed up with a US children’s hospital to kick-off its observational study...
Zelda Therapeutics gets go ahead for medicinal cannabis trial to treat insomnia
In an Australian first, Zelda Therapeutics (ASX: ZLD) has been given the go ahead to begin its...
Treating autism with medicinal cannabis returns positive results for Zelda Therapeutics
The Board of Zelda Therapeutics (ASX: ZLD) has sponsored an observation autism trial in Chile, demonstrating successful results for...
Zelda Therapeutics enters strategic manufacturing and distribution agreement
Zelda Therapeutics (ASX: ZLD) has entered into a strategic manufacturing and distribution agreement with Knop Laboratories SA.
Key...
Zelda Therapeutics reports positive results in breast cancer study using cannabinoids
Zelda Therapeutics (ASX: ZLD) has reported positive results from its ongoing pre-clinical research into the use of cannabinoids...